Portopulmonary hypertension epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Overview

Epidemiology and Demographics

PPH presents roughly equally in male and female cirrhotics; 71% female in an American series and 57% male in a larger French series.^[1]^[2] Typically, patients present in their fifth decade, aged 49 +/- 11 years on average.^[1]^[3]

References

↑ ^1.0 ^1.1 Le Pavec et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med Vol 178. pp 637–643, 2008
↑ Kawut SM et al. Clinical Risk Factors for Portopulmonary Hypertension. Hepatology 2008;48
↑ Bejaminov et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003; 52:1355-1362

Template:WS Template:WH

[LePavec-1] 1.0 ^1.1 Le Pavec et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med Vol 178. pp 637–643, 2008

[Kawut-2] Kawut SM et al. Clinical Risk Factors for Portopulmonary Hypertension. Hepatology 2008;48

[3] Bejaminov et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003; 52:1355-1362

[1]

[2]

[3]